Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
Travere Therapeutics
May 11, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Adventist Health plans a $220 million expansion at a hospital it acquired from Tenet. The coverage frames the project as an add-on following the prior hospital acquisition.
The excerpt provides the expansion amount but does not add further operational or financial details.
Source
Read full article on news.google.comvia GN - site:beckershospitalreview.com · January 21, 2026
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Travere Therapeutics
May 11, 2026
Pharvaris
May 11, 2026
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical
May 11, 2026